<DOC>
	<DOCNO>NCT03022344</DOCNO>
	<brief_summary>However , sparse information regard atherosclerotic burden cardiovascular biomarkers early stage type-2 diabetes , vast majority study concern diabetes population 5 year average diabetes age high-risk subgroup , inclusion already atherosclerotic disease manifestation . Consequently , study aim evaluate occurrence early-stage subclinical atherosclerosis newly diagnose type-2 diabetes special emphasis coronary plaque characteristic modern image technique . These finding compare functional status various peripheral arterial segment biomarkers cross-sectional part study . The 5-year follow-up study intend describe relationship select measure general atherosclerotic involvement progression coronary atherosclerotic burden contemporary technique .</brief_summary>
	<brief_title>DD2-Coronary Plaque Morphology Plaque Progression</brief_title>
	<detailed_description>THE AIM The objective study : Study I : Compare prevalence complexity coronary plaque patient newly discover type-2 diabetes healthy control group match age gender , evaluate coronary compute tomography angiography . Study II : Describe relationship morphological , functional biochemical estimate arteriosclerosis newly diagnose type-2 diabetes . Study III : Characterize progression coronary plaque patient newly discover type-2 diabetes 5-year follow-up study . DESIGN `` Coronary plaque morphology plaque progression patient newly diagnose type-2 diabetes mellitus '' ( DD2-plaque study ) prospective cohort follow study . The inclusion phase run 2 year . The follow-up phase 5 year inclusion . The DD2-plaque study ( diabetic patient 's cohort ) : Recruitment cohort take place three way : 1 . From `` Danish center strategic research type 2 diabetes '' ( DD2 ) - patient agree contacted participation future study . 2 . Direct outpatient clinics The Region Southern . Patients either recruit general practitioner outpatient clinic The Region Southern Denmark . The investigator expect able include 100 asymptomatic patient newly diagnose type-2 diabetes . Inclusion criteria 1 . Newly diagnose ( &lt; 1 year ) diabetes patient clinically classify type-2 diabetes patient sex . 2 . Age 18 + . Exclusion criteria 1 . Type 1 diabetes ( age &lt; 30 year C-peptid &lt; 300pmol/l GAD-ab titer &gt; 20 IU/ml ) . 2 . Renal insufficiency ( GFR &lt; 45 se-creatinine &gt; 140 micromol/l ) . 3 . BMI &gt; 35 kg/m2 4 . Atrial fibrillation . 5 . Life expectancy 2 year . 6 . Mental disease and/or misuse alcohol drug affect patient 's ability give inform consent . 7 . Pregnancy time plan inclusion . 8 . Patients history prior atherothrombotic disease ( include acute coronary syndrome , prior revascularization , ischemic stroke peripheral arterial disease ) . The DD2-plaque study ( control patient cohort ) : 100 control recruit general population advertisement local press . Controls cardiovascular disease ( criteria consistent describe patient type-2 diabetes ) type-2 diabetes ( undiagnosed type-2 diabetes group exclude fast plasma glucose oral glucose tolerance test ) exclude . In addition , exclusion criterion also consistent describe patient type-2 diabetes . Longitudinal measurement do screen visit 5 year . 1 . The proxy statement . 2 . Participants fill questionnaire concerning : - Cardiovascular diabetes hereditary - Medication - Alcohol drug consumption - Smoking habit ( current , prior never smoker ) - Family history ( cardiac event stroke woman &lt; 65 year age men &lt; 55 year age first generation relative ) - Medical history 3 . Physical examination include measurement : - Height , weight , BMI . - Waist/hip ratio - ECG 4 . Brachial blood pressure measure oscillometric technics 24 hour use TM-2430 ( A &amp; D CO. , LTD , Saitama , Japan ) BDM Mobil-O-Graph® NG Classic ( IEM GmbH , Stolberg , Germany ) . 5 . Blood sample : Procedures handle shipping sample available trial master www.DD2.nu `` blodprøvetagning '' . An exception procedure blood sample freeze site send ice biobank . 2 x 9 ml . container green lid ( Li-hep ) 2 x 2.7 ml . container blue lid ( Na-citrat ) 2 x 9 ml . container purple lid ( EDTA ) 2 x 4 ml . container purple/dark purple lid ( EDTA ) 2 x 3 ml . container pink lid ( Fluoridcitrat ) 2 x 9 ml . container brown lid ( Serum ) 1 container urine yellow lid 10 ml morning midstream urine sample . Urine stick use rule urinary tract infection . If present urine resemble . A total 73.4 ml + 10 ml blood drawn . For subset patient DD2 cohort registration baseline visit take place day . These patient 146.8 ml blood drawn day . Containers send patient . 6 . Biochemical analysis : total cholesterol , S-LDL-cholesterol , S-HDL-cholesterol S-triglycerides , HbA1c , glucose , C-reactive protein , D-dimer , creatinin fibrinogen . All analysis perform local Dept . Clinical Biochemistry . 7 . All patient undergone : Carotid intima medium thickness ( IMT ) measure B-mode ultrasound ( Model IE33 , Koninklijke Philips Electronics N.V , Eindhoven , The Netherlands ) use linear array transducer , L11-3 frequency 11 MHz . 8 . Pulse wave velocity : Using sphygmocor ( ArtCor , Sydney , Australia ) . 9 . Ankle brachial index . 10 . Albumin creatinine ratio 11 . Coronary atherosclerosis evaluate measurement calcium coronary artery evaluation coronary plaque use contrast enhance cardiac CT. Coronary artery calcification estimate Agatston score evaluation coronary plaque perform dedicated plaque-analysis tool , Auto-Plaque . STATISTICS Sample size estimation perform comparison calcium score patient type-2 diabetes normal control ( Un-paired evaluation ) comparison calcium score type-2 diabetes patient inclusion follow-up ( Paired ) . From previous study calcium score Danish Risk Score Study cohort , standard deviation , SD , coronary calcification know 32.7 UE ( Agatston Score ) . It suppose SD diabetic patient equal figure control . Under assumption 15 % drop-out , MIREDIF 20 ( twice threshold register occurrence coronary calcification central West Danish Heart Registry , VDH ) , beta= 0 , 1 alfa= 0.02 ( Planned comparative analysis 2-3 plaque-components ) calculate , need include 41 patient group un-paired analysis follow 41 diabetic patient 5 year ( Paired analysis ) . It suppose , app . 40 % type-2 diabetes patient meet age criterion ( 55+/-5 year 65+/-5 year ) comparison background population , mean app . 100 type-2 diabetes patient include DD2 plaque study . Students T-test use comparison normally distribute continuous variable Mann-Whitney test use comparison continuous variable normally distribute . The χ2- test perform comparison dichotomous variable . Continuous variable present either mean standard deviation median interquartile range . P-values &lt; 0.05 consider statistically significant . Stepwise multivariate logistic regression perform analysis factor associate coronary atherosclerosis use either presence coronary artery calcification plaque variable dependant variable .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Newly diagnose ( &lt; 1 year ) diabetes patient clinically classify type2 diabetes patient sex . Age 18 + . Type 1 diabetes ( age &lt; 30 year Cpeptid &lt; 300pmol/l GADab titer &gt; 20 IU/ml ) . Renal insufficiency ( GFR &lt; 45 secreatinine &gt; 140 micromol/l ) . BMI &gt; 35 . Atrial fibrillation . Life expectancy 2 year . Mental disease and/or misuse alcohol drug affect patient 's ability give inform consent . Pregnancy time plan inclusion . Patients history prior atherothrombotic disease ( include acute coronary syndrome , prior revascularization , ischemic stroke peripheral arterial disease ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>DD2 plaque study</keyword>
	<keyword>Coronary plaque</keyword>
	<keyword>Type-2 diabetes mellitus</keyword>
</DOC>